Brazil moves to limit medtech mercury use
This article was originally published in Clinica
Brazil is seeking to restrict the use of mercury in medical devices, in line with healthcare safety and manufacturing policies in other countries. Regulatory agency Anvisa yesterday hosted a “technical panel” consisting of representatives from the medtech industry, the health services, academia and the government.
You may also be interested in...
Market Intel: After A Year Of Partnerships, Insulin Pump Manufacturers Will Face Fierce Competition In 2020
The insulin pump market is expected to grow to $5.1bn by 2023, driven by the increasing incidence of diabetes and adoption of next-generation hybrid closed-loop systems that allow patients and health-care providers to better manage care. This first part of a two-part series highlights the rising competitive landscape of the four major players, Medtronic, Insulet, Tandem Diabetes Care and Valeritas, with insights from endocrinologists. The second part will look at the smaller players, which are also gearing up to introduce new products in 2020.
CMR Surgical CEO Martin Frost is making way for a new boss to lead the surgical robotics company. Per Vegard Nerseth is set to join CMR Surgical in January 2020 as the company gears up for its most ambitious year yet.
While the BCMA-targeting CAR-T competition is grabbing attention, bluebird has good news in sickle cell therapy.